Calcification: From pathological process to therapeutic strategy
BME Horizon · 2024
DOI: 10.70401/bmeh.2026.0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Horizon, 2024. Verfasst von Chi Zhang und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Pathological calcification is typically regarded as a pathological endpoint, representing the abnormal deposition of calcium salts in tissues. With the continuous advancement of research, scientists have explored novel therapeutic strategies involving the induced calcification of tumor cells, demonstrating its potential therapeutic capabilities. Recently, a pioneering study on the use of induced calcification to treat bacterial infections has been reported. This commentary first introduces the classification, etiology, and treatment of pathological calcification. Then, the antibacterial effects of induced calcification therapy through the delicately designed antibacterial agent against methicillin-resistant Staphylococcus aureus (MRSA) are generally demonstrated and discussed. The underlying mechanism of induced calcification for the treatment of chronic lung infections and chronic osteomyelitis caused by MRSA is revealed from the perspectives of bacterial energy metabolism and immune modulation. At the end of this commentary, challenges and future directions for induced calcification therapy are also briefly presented.
Zitieren
APA
Zhang, C., Zhang, H., Zhang, Q., & Yuwen, L. (2024). Calcification: From pathological process to therapeutic strategy. BME Horizon. https://doi.org/10.70401/bmeh.2026.0016
Vancouver
Zhang C, Zhang H, Zhang Q, Yuwen L. Calcification: From pathological process to therapeutic strategy. BME Horizon. 2024. doi:10.70401/bmeh.2026.0016
BibTeX
@article{Zhang2024,
author = {Zhang, Chi and Zhang, Heng and Zhang, Qi and Yuwen, Lihui},
title = {Calcification: From pathological process to therapeutic strategy},
journal = {BME Horizon},
year = {2024},
doi = {10.70401/bmeh.2026.0016}
}
EUVIMED